Table 2.
Prognostic parameters in patients with unresectable advanced colorectal carcinoma
| n | MST (months) | P | ||
|---|---|---|---|---|
| Age (years) |
≥75 |
22 |
9 |
0.303 |
| <75 |
39 |
9 |
||
| ECOG-PS |
0 or 1 |
46 |
10 |
0.022 |
| 2 or 3 |
15 |
5 |
||
| GPS |
0 or 1 |
37 |
12 |
<0.001 |
| 2 |
24 |
4 |
||
| NLR |
≥5 |
29 |
4 |
0.002 |
| <5 |
32 |
13 |
||
| PNI |
≥40 |
35 |
10 |
0.002 |
| <40 |
26 |
4 |
||
| CEA (ng/mL) | ≥10 |
33 |
9 |
0.268 |
| <10 | 28 | 9 |
CEA, carcinoembryonic antigen; ECOG-PS, Eastern Cooperative Oncology Group Performance Status; GPS, Glasgow Prognostic Score; MST, median survival time; NLR, neutrophil/lymphocyte ratio; PNI, prognostic nutritional index.